Table 3 Malaria prevalence in candidate blood donors in the American continent

Manaus, Brazil

407 blood donors

Microscopy

0.0

–

Torres et al. [33]

RDT

0.0

–

São Paulo, Brazil

1108 blood donors

PCR

7.5

P. falciparum (5.1)

Maselli et al. [35]

P. vivax (2.3)

Mixed P. falciparum–P. vivax infection (0.1)

USA

5610 malaria-deferred donors

EIA

1.6

NA

Nguyen et al. [34]

PCR

0.0

–

Pará, Brazil

595 blood donors

PCR

1.3

P. vivax (1.3)

Batista-dos-Santos et al. [42]

Caracas, Ciudad Bolívar, Puerto Ayacucho and Cumaná, Venezuela

762 blood donors

Direct EIA

2.4

NA

Contreras et al. [36]

Microscopy

0.0

–

PCR

0.0

–

Porto Velho (RO), Brazil

100 blood donors

PCR

3.0

Mixed P. falciparum–P. vivax infection (2.3)

Fugikaha et al. [43]

Macapá (AP), Brazil

100 blood donors

PCR

3.0

Mixed P. falciparum–P. vivax infection (2.3)

Belém (PA), Brazil

100 blood donors

PCR

2.0

Mixed P. falciparum–P. vivax infection (2.3)

Rio Branco (AC), Brazil

100 blood donors

PCR

1.0

Mixed P. falciparum–P. vivax infection (2.3)

Manaus (AM), Brazil

286 blood donors

Microscopy

0.0

–

Torres et al. [32]

QBC

0.0

–

PCR

0.3

P. vivax (0.3)

Manaus (AM), Brazil

38 deferred donations

Microscopy

0.0

–

Torres et al. [32]

QBC

1.4

NA

PCR

0.0

–

Caracas, Venezuela

500 blood donors

IIF (IgG Pf)

0.8

P. falciparum (0.8)

Contreras et al. [39]

ELISA (IgG Pf)

0.8

P. falciparum (0.8)

Ciudad Bolívar, Venezuela

500 blood donors

IIF (IgG Pf)

3.8

P. falciparum (3.8)

Contreras et al. [39]

ELISA (IgG Pf)

2.0

P. falciparum (2.0)

Cali, Colombia

286 blood donors

Microscopy

0.0

–

Castillo and Ramírez [22]

EIA IgG

0.0

–

EIA HRPII

0.0

–

PCR

0.0

–

São Paulo (SP), Brazil

1164 blood donors

Microscopy

0.0

–

Sáez-Alquézar et al. [27]

DIF

0.0

–

IIF IgG anti-Pv

–

P. vivax (1.2)

IIF IgG anti-Pf

–

P. falciparum (0.9)

ELISA IgG Pf

–

P. falciparum (1.0)

36 deferred donations

Microscopy

0.0

–

DIF

0.0

–

IIF IgG anti-Pv

–

P. vivax (16.7)

IIF IgG anti-Pf

–

P. falciparum (5.6)

ELISA IgG Pf

–

P. falciparum (2.7)

Belém (PA), Brazil

238 blood donors

Microscopy

0.0

–

Sáez-Alquézar et al. [27]

QBC

0.0

–

DIF

0.0

–

IIF IgG anti-Pv

–

P. vivax (9.6)

IIF IgG anti-Pf

–

P. falciparum (10.1)

ELISA IgG Pf

P. falciparum (17.2)

12 deferred donations

Microscopy

0.0

–

QBC

0.0

–

DIF

0.0

–

IIF IgG anti-Pv

–

P. vivax (25.0)

IIF IgG anti-Pf

–

P. falciparum (41.6)

ELISA IgG Pf

P. falciparum (25.0)

Matupá and Peixoto de Azevedo (MT), Brazil

31 blood donors

Microscopy

0.0

–

DIF

0.0

–

IIF IgG anti-Pv

–

P. vivax (74.2)

IIF IgG anti-Pf

–

P. falciparum (64.5)

ELISA IgG Pf

–

P. falciparum (54.8)

Porto Velho (RO), Brazil

230 blood donors

IIF IgG Pf

–

P. falciparum (32.0)

Ferreira et al. [41]

IIF IgG Pv

–

P. vivax (24.0)

IIF IgM Pf

–

P. falciparum (4.0)

IIF IgM Pv

–

P. vivax (1.0)

Caracas (DF), Venezuela

426 blood donors

EIA IgG Pf

–

P. falciparum (0.0)

Nunez et al. [37]

Cumaná (Sucre), Venezuela

120 blood donors

EIA IgG Pf

–

P. falciparum (2.5)

Nunez et al. [37]

Barcelona (Anzoátegui), Venezuela

285 blood donors

EIA IgG Pf

–

P. falciparum (0.7)

Nunez et al. [37]

San Fernando (Apure), Venezuela

59 blood donors

EIA IgG Pf

–

P. falciparum (1.7)

Nunez et al. [37]

Cali, Colombia

1859 blood donors

EIA IgG Pf

–

P. falciparum (13.4)

de Morales et al. [40]

Bogotá, Colombia

3114 blood donors

EIA IgG Pf

–

P. falciparum (0.9)

de Morales and Espinal [38]

USA

47 (from 117) blood donors suspected to be responsible for 10 TTM cases

IIF Ig anti-Pf+Pv+Pm

19.1

P. falciparum (12.8)

Sulzer and Wilson [44]

P. malariae (6.3)

P. vivax (0.0)